What is LOPJLB’s current signal on ABSI?

LOPJLB’s latest quantitative signal on Absci Corporation (ABSI) is BUY in a CRISIS regime. Signals are updated daily.

What market regime is ABSI in?

Absci Corporation (ABSI) is currently classified in the CRISIS HMM market regime on LOPJLB.

Absci Corporation (ABSI)

COMPARE

Healthcare · Biotechnology · NASDAQ · US

$10.16+13.65%Close

BUYCRISIS · day 3

RANGE

DATA 2026-10-09

LOPJLB.COM

OHLCEMALEVELSSTOPFLIP52WSIGNALSBUYSELLEXHEXH ZONE

Key stats

Short interest · FINRA settlement 2026-09-30

Market cap: $1.7B
Beta: 2.28
P/E (TTM): -12.84

Short % float: 25.49%
Days to cover: 7.5
SI change: +0.5%

1W: -8.22%
1M: +23.30%

vs SPY 1W: -9.38%
vs SPY 1M: +20.31%

Industry peers

FMP comparable companies · ranked by market cap

Prediction markets

Kalshi · Polymarket · … linked

Full prediction markets →

Loading markets…

Company

Absci Corporation operates as a biopharmaceutical company primarily focused on discovering novel drug targets and developing new therapeutic compounds. Leveraging its distinctive integrated drug creation platform, the firm generates potential biologic medicines and essential…

Employees: 140
Headquarters: US
Founded: 2021
Exchange: NASDAQ
Sector: Healthcare
Industry: Biotechnology
Shares out: 169.4M
Float: 86.7%

absci.com ↗

Key executives

Sean McClain — Founder, Chief Executive Officer, President & Director

Zachariah Jonasson — Chief Business Officer & Chief Financial Officer

Amer-Denis Akkad — Vice President of Research

SEC filings

EDGAR · CIK 16726880 · ABSI

Analyst consensus

Buy

Bullish1076.9%

Neutral17.7%

Bearish215.4%

L $10.00Avg $13.60H $16.00

Target$13.60+33.86%

Last$10.16

FAQ

What is LOPJLB’s current signal on ABSI?: LOPJLB’s latest quantitative signal on Absci Corporation (ABSI) is BUY in a CRISIS regime. Signals are updated daily.
What market regime is ABSI in?: Absci Corporation (ABSI) is currently classified in the CRISIS HMM market regime on LOPJLB.
What does Absci Corporation (ABSI) do?: Absci Corporation operates as a biopharmaceutical company primarily focused on discovering novel drug targets and developing new therapeutic compounds. Leveraging its distinctive integrated drug creation platform, the firm generates potential biologic medicines and essential cell lines for manufacturing, which it provides to its collaborators, predominantly within the United States. This advanc…

Key stats

Industry peers

Prediction markets

Company news

FAQ